4506
Sumitomo Pharma Co.,Ltd.
住友ファーマ
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
515,952
Mar 2022
560,035
Mar 2023
555,544
Mar 2024
314,558
Mar 2025
398,832
Operating profit(million JPY)
Mar 2021
71,224
Mar 2022
60,234
Mar 2023
-76,979
Mar 2024
-354,859
Mar 2025
28,804
Operating profit margin(%)
Mar 2021
13.8
Mar 2022
10.76
Mar 2023
-13.86
Mar 2024
-112.81
Mar 2025
7.22
Profit before tax(million JPY)
Mar 2021
77,851
Mar 2022
82,961
Mar 2023
-47,920
Mar 2024
-323,114
Mar 2025
17,611
Profit(million JPY)
Mar 2021
56,219
Mar 2022
56,413
Mar 2023
-74,512
Mar 2024
-314,969
Mar 2025
23,634
Total assets(million JPY)
Mar 2021
1,308,127
Mar 2022
1,308,007
Mar 2023
1,134,742
Mar 2024
907,506
Mar 2025
742,604
Cash and cash equivalents(million JPY)
Mar 2021
193,698
Mar 2022
202,984
Mar 2023
143,478
Mar 2024
29,047
Mar 2025
23,116
Cash flows from operating activities(million JPY)
Mar 2021
135,601
Mar 2022
31,239
Mar 2023
11,937
Mar 2024
-241,893
Mar 2025
16,500
Cash flows from investing activities(million JPY)
Mar 2021
8,875
Mar 2022
-18,278
Mar 2023
52,419
Mar 2024
33,036
Mar 2025
99,754
Cash flows from financing activities(million JPY)
Mar 2021
-57,215
Mar 2022
-21,426
Mar 2023
-146,817
Mar 2024
77,851
Mar 2025
-108,836
Return on equity(%)
Mar 2021
10.1
Mar 2022
9.5
Mar 2023
-14.7
Mar 2024
-111.9
Mar 2025
14.5
Equity ratio(%)
Mar 2021
44.4
Mar 2022
46.5
Mar 2023
35.8
Mar 2024
17.2
Mar 2025
22.8
Earnings per share(JPY per share)
Mar 2021
141.5
Mar 2022
141.99
Mar 2023
-187.55
Mar 2024
-792.79
Mar 2025
59.49
Net assets per share(JPY per share)
Mar 2021
1,461.31
Mar 2022
1,530.08
Mar 2023
1,023.8
Mar 2024
392.82
Mar 2025
426.59
Dividend per share(JPY per share)
Mar 2021
28
Mar 2022
28
Mar 2023
21
Mar 2024
-
Mar 2025
-
Payout ratio(%)
Mar 2021
19.79
Mar 2022
19.72
Mar 2023
-
Mar 2024
-
Mar 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.